Cardiovascular diseases and diabetes mellitus.
Diabetes UK held its Annual Professional Conference on March 29-31, 2006, in Birmingham, United Kingdom. This conference aimed to deliver the latest global developments in diabetes care using basic and clinical science as its cornerstone, and to inspire and support innovation in current practice. This report will examine the advances in different aspects of cardiovascular disease in diabetes mellitus.
Bandyopadhyay
Prabirkumar
P
Sandwell Medical Research Unit, Sandwell and West Birmingham Hospitals NHS Trust, Lyndon, West Bromwich, West Midlands, UK. prabirbanerjee@yahoo.co.uk
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors